LICENSEE and the Clause Samples
LICENSEE and the. REGENTS will hold the other party’s proprietary business information ("Proprietary Information") in confidence, using at least the same degree of care as the receiving party uses to protect its own proprietary information of a similar nature. Proprietary Information will be protected from the date of disclosure until five (5) years after the termination or expiration of this AGREEMENT. INCLUDE THIS IF THERE IS
LICENSEE and the. Licensee Affiliates acknowledge and agree that: (1) the Program and any data generated by the use of the Program is the valuable proprietary property and trade secret of V2K or the V2K Affiliate; (2) they shall use the utmost care to safeguard the Program and any data generated by the use of the Program and to maintain its secrecy and confidentiality; (3) they shall not undertake to patent, copyright or otherwise assert proprietary rights to the Program and any data generated by the use of the Program or any portion of it; and (4) they shall not create any derivative works based on the Software without the prior written consent of V2K.
LICENSEE and the. Regents will treat and maintain the other party’s confidential information, including the negotiated terms of this Agreement, patent prosecution related information, any progress reports and royalty reports and any Sublicense issued pursuant to this Agreement (“Confidential Information”) in confidence using at least the same degree of care as the receiving party uses to protect its own confidential information of a like nature from the date of disclosure until five (5) years after the termination or expiration of this Agreement. Confidential Information can be written, oral, or both.
LICENSEE and the. Regents respectively will treat and maintain the proprietary business, patent prosecution, software, engineering drawings, process and technical information, and other proprietary information ("Proprietary Information") of the other party in confidence using at least the same degree of care as that party uses to protect its own proprietary information of a like nature for a period from the date of disclosure until five years after the date of termination of this Agreement.
LICENSEE and the. REGENTS will assess and amend Exhibit A (LICENSED PATENTS) after completion and full testing of the sub-scale prototype of the DWA in order to determine the Licensed Patents needed for commercialization. The Parties will continue to assess and amend Exhibit A (LICENSED PATENTS) during the course of the CRADA that is currently negotiated with LICENSEE. During this period, THE REGENTS agree to add additional rights to Category 1 Patents, Category 2 Patents, and Category 3 Patents as reasonably necessary to commercialize the Invention in accordance with the provisions herein. THEREFORE, the Parties agree as follows: